About this trial
The investigators conducted a prospective, randomized double-blind, placebo-controlled study based on a placebo technique to evaluate the efficacy of IVES vs perineal ES in women with idiopathic OAB.
The main questions aimed to be answered are:
Is Intravaginal Electrical Stimulation (IVES) or perineal ES more effective on clinical parameters related to incontinence and quality of life in women with idiopathic overactive bladder (OAB)? Participants (n:63) with idiopathic OAB who meet the exclusion and inclusion criteria will be divided into 3 groups using a randomization table. The first group will receive IVES and bladder training (n:21), second group will receive perineal ES and bladder training (n:21) and third group will receive bladder training (n=21) . Measurements will be performed twice in total, before and at the end of treatment (8th week).
Eligibility criteria
Qualifiers
Women over the age of 18 with a clinical diagnosis of idiopathic OAB
Intolerant or unresponsive to antimuscarinic or oral β3 adrenoceptor agonist (mirabegron) medications and not using them for at least 4 weeks
Ability to understand the procedures, advantages, and potential side effects
Ability to provide written, informed consent
Disqualifiers
Women with pure stress urinary incontinence
History of conservative treatment for OAB within the last 6 months (MI, IVES, perineal ES, etc.)
Pregnant or planning to become pregnant at the time of the study
Diagnosis of vaginal infection, urinary tract infection, or cancer
Trial design
Treatments tested in this trial
- Bladder Training + Intravaginal ES
- BT
- Bladder Training + Perineal ES